Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-alpha (MOR-22) against renal cell carcinoma--a multiclinic cooperative, early phase II study. Subcommittee on Urogenital Malignancy, Committee on MHR-24 against Tumors].
Hinyokika kiyo. Acta urologica Japonica·1992
Long-term clinical study on luteinising hormone-releasing hormone agonist depot formulation in the treatment of stage D prostatic cancer. The TAP-144-SR Study Group.
Japanese journal of clinical oncology·1992
[Ablative and prophylactic effects of BCG Tokyo 172 strain for intravesical treatment in patients with superficial bladder cancer and carcinoma in situ of the bladder. Bladder cancer BCG Study Group].
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·1992
An Intravesical Akkermansia muciniphila-Based Chemo-Immunotherapeutic Platform for Bladder Cancer.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
ETS1-EGR2 facilitates renal cell carcinoma progression by activating NOTCH signalling.
Clinical and translational medicine·2026
Aging's Competing Paradigms: Another Decade of Investigation into Damage-Driven versus Programmed Theories.
Ageing research reviews·2026
Research advances in the recurrence patterns of glioblastoma.
Biochimica et biophysica acta. Reviews on cancer·2026